fda import alert green list glp-1 semaglutide tirzepatide 2025 launches 'green list' to block unsafe imported drug ingredients The day after @potus announces
Description
Why does the dose increase in the second half of the cycle
As tirzepatide improves glycaemic control and reduces blood glucose levels, some individuals may experience relative hypoglycaemia, particularly during the initial treatment phase or following dose increases
This collaborative effort helps maintain a steady supply of medications, minimizing the impact of shortages on patient care.
This moment is bigger than one drug or one formulary shift
